TY - STD TI - Christofi T, Baritaki S, Falzone L, Libra M, Zaravinos A. Current Perspectives in Cancer Immunotherapy. Cancers (Basel). 2019;11. ID - ref1 ER - TY - JOUR AU - Hodi, F. S. AU - O'Day, S. J. AU - McDermott, D. F. AU - Weber, R. W. AU - Sosman, J. A. AU - Haanen, J. B. PY - 2010 DA - 2010// TI - Improved survival with ipilimumab in patients with metastatic melanoma JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMoa1003466 DO - 10.1056/NEJMoa1003466 ID - Hodi2010 ER - TY - JOUR AU - Brahmer, J. R. AU - Tykodi, S. S. AU - Chow, L. Q. AU - Hwu, W. J. AU - Topalian, S. L. AU - Hwu, P. PY - 2012 DA - 2012// TI - Safety and activity of anti-PD-L1 antibody in patients with advanced cancer JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMoa1200694 DO - 10.1056/NEJMoa1200694 ID - Brahmer2012 ER - TY - JOUR AU - Topalian, S. L. AU - Hodi, F. S. AU - Brahmer, J. R. AU - Gettinger, S. N. AU - Smith, D. C. AU - McDermott, D. F. PY - 2012 DA - 2012// TI - Safety, activity, and immune correlates of anti-PD-1 antibody in cancer JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMoa1200690 DO - 10.1056/NEJMoa1200690 ID - Topalian2012 ER - TY - JOUR AU - Darnell, J. E. AU - Kerr, I. M. AU - Stark, G. R. PY - 1994 DA - 1994// TI - Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins JO - Science. VL - 264 UR - https://doi.org/10.1126/science.8197455 DO - 10.1126/science.8197455 ID - Darnell1994 ER - TY - JOUR AU - Hanlon, M. M. AU - Rakovich, T. AU - Cunningham, C. C. AU - Ansboro, S. AU - Veale, D. J. AU - Fearon, U. PY - 2019 DA - 2019// TI - STAT3 Mediates the Differential Effects of Oncostatin M and TNFalpha on RA Synovial Fibroblast and Endothelial Cell Function JO - Front Immunol VL - 10 UR - https://doi.org/10.3389/fimmu.2019.02056 DO - 10.3389/fimmu.2019.02056 ID - Hanlon2019 ER - TY - JOUR AU - Rawlings, J. S. AU - Rosler, K. M. AU - Harrison, D. A. PY - 2004 DA - 2004// TI - The JAK/STAT signaling pathway JO - J Cell Sci VL - 117 UR - https://doi.org/10.1242/jcs.00963 DO - 10.1242/jcs.00963 ID - Rawlings2004 ER - TY - JOUR AU - Johnson, D. E. AU - O'Keefe, R. A. AU - Grandis, J. R. PY - 2018 DA - 2018// TI - Targeting the IL-6/JAK/STAT3 signalling axis in cancer JO - Nat Rev Clin Oncol VL - 15 UR - https://doi.org/10.1038/nrclinonc.2018.8 DO - 10.1038/nrclinonc.2018.8 ID - Johnson2018 ER - TY - JOUR AU - Ishibashi, K. AU - Koguchi, T. AU - Matsuoka, K. AU - Onagi, A. AU - Tanji, R. AU - Takinami-Honda, R. PY - 2018 DA - 2018// TI - Interleukin-6 induces drug resistance in renal cell carcinoma JO - Fukushima J Med Sci VL - 64 UR - https://doi.org/10.5387/fms.2018-15 DO - 10.5387/fms.2018-15 ID - Ishibashi2018 ER - TY - JOUR AU - Priego, N. AU - Zhu, L. AU - Monteiro, C. AU - Mulders, M. AU - Wasilewski, D. AU - Bindeman, W. PY - 2018 DA - 2018// TI - STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis JO - Nat Med VL - 24 UR - https://doi.org/10.1038/s41591-018-0044-4 DO - 10.1038/s41591-018-0044-4 ID - Priego2018 ER - TY - JOUR AU - Bromberg, J. F. AU - Wrzeszczynska, M. H. AU - Devgan, G. AU - Zhao, Y. AU - Pestell, R. G. AU - Albanese, C. PY - 1999 DA - 1999// TI - Stat3 as an oncogene JO - Cell. VL - 98 UR - https://doi.org/10.1016/S0092-8674(00)81959-5 DO - 10.1016/S0092-8674(00)81959-5 ID - Bromberg1999 ER - TY - JOUR AU - Wang, T. AU - Fahrmann, J. F. AU - Lee, H. AU - Li, Y. J. AU - Tripathi, S. C. AU - Yue, C. PY - 2018 DA - 2018// TI - JAK/STAT3-Regulated Fatty Acid beta-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance JO - Cell Metab VL - 27 UR - https://doi.org/10.1016/j.cmet.2017.11.001 DO - 10.1016/j.cmet.2017.11.001 ID - Wang2018 ER - TY - JOUR AU - Kortylewski, M. AU - Kujawski, M. AU - Wang, T. AU - Wei, S. AU - Zhang, S. AU - Pilon-Thomas, S. PY - 2005 DA - 2005// TI - Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity JO - Nat Med VL - 11 UR - https://doi.org/10.1038/nm1325 DO - 10.1038/nm1325 ID - Kortylewski2005 ER - TY - JOUR AU - Villarino, A. V. AU - Kanno, Y. AU - O'Shea, J. J. PY - 2017 DA - 2017// TI - Mechanisms and consequences of Jak-STAT signaling in the immune system JO - Nat Immunol VL - 18 UR - https://doi.org/10.1038/ni.3691 DO - 10.1038/ni.3691 ID - Villarino2017 ER - TY - STD TI - Sgrignani J, Garofalo M, Matkovic M, Merulla J, Catapano CV, Cavalli A. Structural Biology of STAT3 and Its Implications for Anticancer Therapies Development. Int J Mol Sci. 2018;19. ID - ref15 ER - TY - JOUR AU - Nadiminty, N. AU - Lou, W. AU - Lee, S. O. AU - Lin, X. AU - Trump, D. L. AU - Gao, A. C. PY - 2006 DA - 2006// TI - Stat3 activation of NF-{kappa} B p100 processing involves CBP/p300-mediated acetylation JO - Proc Natl Acad Sci U S A VL - 103 UR - https://doi.org/10.1073/pnas.0509808103 DO - 10.1073/pnas.0509808103 ID - Nadiminty2006 ER - TY - JOUR AU - Gambi, G. AU - Simone, E. AU - Basso, V. AU - Ricci, L. AU - Wang, R. AU - Verma, A. PY - 2019 DA - 2019// TI - The Transcriptional Regulator Sin3A Contributes to the Oncogenic Potential of STAT3 JO - Cancer Res VL - 79 UR - https://doi.org/10.1158/0008-5472.CAN-18-0359 DO - 10.1158/0008-5472.CAN-18-0359 ID - Gambi2019 ER - TY - JOUR AU - Nie, Y. AU - Erion, D. M. AU - Yuan, Z. AU - Dietrich, M. AU - Shulman, G. I. AU - Horvath, T. L. PY - 2009 DA - 2009// TI - STAT3 inhibition of gluconeogenesis is downregulated by SirT1 JO - Nat Cell Biol VL - 11 UR - https://doi.org/10.1038/ncb1857 DO - 10.1038/ncb1857 ID - Nie2009 ER - TY - JOUR AU - Ma, L. AU - Huang, C. AU - Wang, X. J. AU - Xin, D. E. AU - Wang, L. S. AU - Zou, Q. C. PY - 2017 DA - 2017// TI - Lysyl Oxidase 3 Is a Dual-Specificity Enzyme Involved in STAT3 Deacetylation and Deacetylimination Modulation JO - Mol Cell VL - 65 UR - https://doi.org/10.1016/j.molcel.2016.12.002 DO - 10.1016/j.molcel.2016.12.002 ID - Ma2017 ER - TY - JOUR AU - Kim, E. AU - Kim, M. AU - Woo, D. H. AU - Shin, Y. AU - Shin, J. AU - Chang, N. PY - 2013 DA - 2013// TI - Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells JO - Cancer Cell VL - 23 UR - https://doi.org/10.1016/j.ccr.2013.04.008 DO - 10.1016/j.ccr.2013.04.008 ID - Kim2013 ER - TY - JOUR AU - Yang, J. AU - Huang, J. AU - Dasgupta, M. AU - Sears, N. AU - Miyagi, M. AU - Wang, B. PY - 2010 DA - 2010// TI - Reversible methylation of promoter-bound STAT3 by histone-modifying enzymes JO - Proc Natl Acad Sci U S A VL - 107 UR - https://doi.org/10.1073/pnas.1016147107 DO - 10.1073/pnas.1016147107 ID - Yang2010 ER - TY - JOUR AU - Li, L. X. AU - Fan, L. X. AU - Zhou, J. X. AU - Grantham, J. J. AU - Calvet, J. P. AU - Sage, J. PY - 2017 DA - 2017// TI - Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease JO - J Clin Invest VL - 127 UR - https://doi.org/10.1172/JCI90921 DO - 10.1172/JCI90921 ID - Li2017 ER - TY - JOUR AU - Zhou, Z. AU - Wang, M. AU - Li, J. AU - Xiao, M. AU - Chin, Y. E. AU - Cheng, J. PY - 2016 DA - 2016// TI - SUMOylation and SENP3 regulate STAT3 activation in head and neck cancer JO - Oncogene. VL - 35 UR - https://doi.org/10.1038/onc.2016.124 DO - 10.1038/onc.2016.124 ID - Zhou2016 ER - TY - JOUR AU - Lin, W. AU - Luo, J. AU - Sun, Y. AU - Lin, C. AU - Li, G. AU - Niu, Y. PY - 2018 DA - 2018// TI - ASC-J9((R)) suppresses prostate cancer cell invasion via altering the sumoylation-phosphorylation of STAT3 JO - Cancer Lett VL - 425 UR - https://doi.org/10.1016/j.canlet.2018.02.007 DO - 10.1016/j.canlet.2018.02.007 ID - Lin2018 ER - TY - JOUR AU - Zhang, L. AU - Li, J. AU - Wang, Q. AU - Meng, G. AU - Lv, X. AU - Zhou, H. PY - 2017 DA - 2017// TI - The relationship between microRNAs and the STAT3-related signaling pathway in cancer JO - Tumour Biol VL - 39 ID - Zhang2017 ER - TY - JOUR AU - Huan, L. AU - Liang, L. H. AU - He, X. H. PY - 2016 DA - 2016// TI - Role of microRNAs in inflammation-associated liver cancer JO - Cancer Biol Med VL - 13 UR - https://doi.org/10.20892/j.issn.2095-3941.2016.0071 DO - 10.20892/j.issn.2095-3941.2016.0071 ID - Huan2016 ER - TY - JOUR AU - Guo, R. AU - Wu, Z. AU - Wang, J. AU - Li, Q. AU - Shen, S. AU - Wang, W. PY - 2019 DA - 2019// TI - Development of a Non-Coding-RNA-based EMT/CSC Inhibitory Nanomedicine for In Vivo Treatment and Monitoring of HCC JO - Adv Sci (Weinh) VL - 6 UR - https://doi.org/10.1002/advs.201801885 DO - 10.1002/advs.201801885 ID - Guo2019 ER - TY - JOUR AU - Yang, Y. AU - Ding, L. AU - Hu, Q. AU - Xia, J. AU - Sun, J. AU - Wang, X. PY - 2017 DA - 2017// TI - MicroRNA-218 functions as a tumor suppressor in lung cancer by targeting IL-6/STAT3 and negatively correlates with poor prognosis JO - Mol Cancer VL - 16 UR - https://doi.org/10.1186/s12943-017-0710-z DO - 10.1186/s12943-017-0710-z ID - Yang2017 ER - TY - JOUR AU - Zhang, X. AU - Sai, B. AU - Wang, F. AU - Wang, L. AU - Wang, Y. AU - Zheng, L. PY - 2019 DA - 2019// TI - Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT JO - Mol Cancer VL - 18 UR - https://doi.org/10.1186/s12943-019-0959-5 DO - 10.1186/s12943-019-0959-5 ID - Zhang2019 ER - TY - JOUR AU - Jin, S. AU - Yang, X. AU - Li, J. AU - Yang, W. AU - Ma, H. AU - Zhang, Z. PY - 2019 DA - 2019// TI - p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma JO - Mol Cancer VL - 18 UR - https://doi.org/10.1186/s12943-019-0993-3 DO - 10.1186/s12943-019-0993-3 ID - Jin2019 ER - TY - JOUR AU - Luo, Z. AU - Cao, P. PY - 2019 DA - 2019// TI - Long noncoding RNA PVT1 promotes hepatoblastoma cell proliferation through activating STAT3 JO - Cancer Manag Res VL - 11 UR - https://doi.org/10.2147/CMAR.S213707 DO - 10.2147/CMAR.S213707 ID - Luo2019 ER - TY - JOUR AU - Wang, S. AU - Liang, K. AU - Hu, Q. AU - Li, P. AU - Song, J. AU - Yang, Y. PY - 2017 DA - 2017// TI - JAK2-binding long noncoding RNA promotes breast cancer brain metastasis JO - J Clin Invest VL - 127 UR - https://doi.org/10.1172/JCI91553 DO - 10.1172/JCI91553 ID - Wang2017 ER - TY - JOUR AU - Liang, C. AU - Zhao, T. AU - Li, H. AU - He, F. AU - Zhao, X. AU - Zhang, Y. PY - 2019 DA - 2019// TI - Long Non-coding RNA ITIH4-AS1 Accelerates the Proliferation and Metastasis of Colorectal Cancer by Activating JAK/STAT3 Signaling JO - Mol Ther Nucleic Acids VL - 18 UR - https://doi.org/10.1016/j.omtn.2019.08.009 DO - 10.1016/j.omtn.2019.08.009 ID - Liang2019 ER - TY - STD TI - Pichler M, Rodriguez-Aguayo C, Nam SY, Dragomir MP, Bayraktar R, Anfossi S, et al. Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer. Gut. 2020. ID - ref34 ER - TY - STD TI - Wang Y, Wu S, Zhu X, Zhang L, Deng J, Li F, et al. LncRNA-encoded polypeptide ASRPS inhibits triple-negative breast cancer angiogenesis. J Exp Med. 2020;217. ID - ref35 ER - TY - JOUR AU - Hu, D. AU - Zhang, Y. PY - 2019 DA - 2019// TI - Circular RNA HIPK3 promotes glioma progression by binding to miR-124-3p JO - Gene. VL - 690 UR - https://doi.org/10.1016/j.gene.2018.11.073 DO - 10.1016/j.gene.2018.11.073 ID - Hu2019 ER - TY - JOUR AU - Dong, Y. AU - Xu, T. AU - Zhong, S. AU - Wang, B. AU - Zhang, H. AU - Wang, X. PY - 2019 DA - 2019// TI - Circ_0076305 regulates cisplatin resistance of non-small cell lung cancer via positively modulating STAT3 by sponging miR-296-5p JO - Life Sci VL - 239 UR - https://doi.org/10.1016/j.lfs.2019.116984 DO - 10.1016/j.lfs.2019.116984 ID - Dong2019 ER - TY - JOUR AU - Liu, Y. AU - Song, J. AU - Liu, Y. AU - Zhou, Z. AU - Wang, X. PY - 2020 DA - 2020// TI - Transcription activation of circ-STAT3 induced by Gli2 promotes the progression of hepatoblastoma via acting as a sponge for miR-29a/b/c-3p to upregulate STAT3/Gli2 JO - J Exp Clin Cancer Res VL - 39 UR - https://doi.org/10.1186/s13046-020-01598-8 DO - 10.1186/s13046-020-01598-8 ID - Liu2020 ER - TY - JOUR AU - Iliopoulos, D. AU - Jaeger, S. A. AU - Hirsch, H. A. AU - Bulyk, M. L. AU - Struhl, K. PY - 2010 DA - 2010// TI - STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer JO - Mol Cell VL - 39 UR - https://doi.org/10.1016/j.molcel.2010.07.023 DO - 10.1016/j.molcel.2010.07.023 ID - Iliopoulos2010 ER - TY - JOUR AU - Loffler, D. AU - Brocke-Heidrich, K. AU - Pfeifer, G. AU - Stocsits, C. AU - Hackermuller, J. AU - Kretzschmar, A. K. PY - 2007 DA - 2007// TI - Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer JO - Blood. VL - 110 UR - https://doi.org/10.1182/blood-2007-03-081133 DO - 10.1182/blood-2007-03-081133 ID - Loffler2007 ER - TY - JOUR AU - Gao, H. AU - Liu, R. AU - Sun, X. PY - 2019 DA - 2019// TI - STAT3-induced upregulation of lncRNA SNHG17 predicts a poor prognosis of melanoma and promotes cell proliferation and metastasis through regulating PI3K-AKT pathway JO - Eur Rev Med Pharmacol Sci VL - 23 ID - Gao2019 ER - TY - JOUR AU - Du, C. AU - Wang, H. X. AU - Chen, P. AU - Chen, C. H. PY - 2019 DA - 2019// TI - STAT3-induced upregulation of lncRNA DUXAP8 functions as ceRNA for miR-577 to promote the migration and invasion in colorectal cancer through the regulation of RAB14 JO - Eur Rev Med Pharmacol Sci VL - 23 ID - Du2019 ER - TY - JOUR AU - Chen, J. F. AU - Wu, P. AU - Xia, R. AU - Yang, J. AU - Huo, X. Y. AU - Gu, D. Y. PY - 2018 DA - 2018// TI - STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy JO - Mol Cancer VL - 17 UR - https://doi.org/10.1186/s12943-017-0756-y DO - 10.1186/s12943-017-0756-y ID - Chen2018 ER - TY - JOUR AU - Yu, H. AU - Pardoll, D. AU - Jove, R. PY - 2009 DA - 2009// TI - STATs in cancer inflammation and immunity: a leading role for STAT3 JO - Nat Rev Cancer VL - 9 UR - https://doi.org/10.1038/nrc2734 DO - 10.1038/nrc2734 ID - Yu2009 ER - TY - JOUR AU - Pearce, O. M. T. AU - Delaine-Smith, R. M. AU - Maniati, E. AU - Nichols, S. AU - Wang, J. AU - Bohm, S. PY - 2018 DA - 2018// TI - Deconstruction of a Metastatic Tumor Microenvironment Reveals a Common Matrix Response in Human Cancers JO - Cancer Discov VL - 8 UR - https://doi.org/10.1158/2159-8290.CD-17-0284 DO - 10.1158/2159-8290.CD-17-0284 ID - Pearce2018 ER - TY - JOUR AU - Azizi, E. AU - Carr, A. J. AU - Plitas, G. AU - Cornish, A. E. AU - Konopacki, C. AU - Prabhakaran, S. PY - 2018 DA - 2018// TI - Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment JO - Cell. VL - 174 UR - https://doi.org/10.1016/j.cell.2018.05.060 DO - 10.1016/j.cell.2018.05.060 ID - Azizi2018 ER - TY - STD TI - Martin JD, Cabral H, Stylianopoulos T, Jain RK. Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges. Nat Rev Clin Oncol. 2020. ID - ref47 ER - TY - JOUR AU - Phuengkham, H. AU - Ren, L. AU - Shin, I. W. AU - Lim, Y. T. PY - 2019 DA - 2019// TI - Nanoengineered Immune Niches for Reprogramming the Immunosuppressive Tumor Microenvironment and Enhancing Cancer Immunotherapy JO - Adv Mater VL - 31 UR - https://doi.org/10.1002/adma.201803322 DO - 10.1002/adma.201803322 ID - Phuengkham2019 ER - TY - JOUR AU - Herrmann, A. AU - Kortylewski, M. AU - Kujawski, M. AU - Zhang, C. AU - Reckamp, K. AU - Armstrong, B. PY - 2010 DA - 2010// TI - Targeting Stat3 in the myeloid compartment drastically improves the in vivo antitumor functions of adoptively transferred T cells JO - Cancer Res VL - 70 UR - https://doi.org/10.1158/0008-5472.CAN-10-0736 DO - 10.1158/0008-5472.CAN-10-0736 ID - Herrmann2010 ER - TY - JOUR AU - Iwata-Kajihara, T. AU - Sumimoto, H. AU - Kawamura, N. AU - Ueda, R. AU - Takahashi, T. AU - Mizuguchi, H. PY - 2011 DA - 2011// TI - Enhanced cancer immunotherapy using STAT3-depleted dendritic cells with high Th1-inducing ability and resistance to cancer cell-derived inhibitory factors JO - J Immunol VL - 187 UR - https://doi.org/10.4049/jimmunol.1002067 DO - 10.4049/jimmunol.1002067 ID - Iwata-Kajihara2011 ER - TY - JOUR AU - Siegel, A. M. AU - Heimall, J. AU - Freeman, A. F. AU - Hsu, A. P. AU - Brittain, E. AU - Brenchley, J. M. PY - 2011 DA - 2011// TI - A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory JO - Immunity. VL - 35 UR - https://doi.org/10.1016/j.immuni.2011.09.016 DO - 10.1016/j.immuni.2011.09.016 ID - Siegel2011 ER - TY - JOUR AU - Gotthardt, D. AU - Putz, E. M. AU - Straka, E. AU - Kudweis, P. AU - Biaggio, M. AU - Poli, V. PY - 2014 DA - 2014// TI - Loss of STAT3 in murine NK cells enhances NK cell-dependent tumor surveillance JO - Blood. VL - 124 UR - https://doi.org/10.1182/blood-2014-03-564450 DO - 10.1182/blood-2014-03-564450 ID - Gotthardt2014 ER - TY - JOUR AU - Wang, T. AU - Niu, G. AU - Kortylewski, M. AU - Burdelya, L. AU - Shain, K. AU - Zhang, S. PY - 2004 DA - 2004// TI - Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells JO - Nat Med VL - 10 UR - https://doi.org/10.1038/nm976 DO - 10.1038/nm976 ID - Wang2004 ER - TY - JOUR AU - Icardi, L. AU - Lievens, S. AU - Mori, R. AU - Piessevaux, J. AU - Cauwer, L. AU - Bosscher, K. PY - 2012 DA - 2012// TI - Opposed regulation of type I IFN-induced STAT3 and ISGF3 transcriptional activities by histone deacetylases (HDACS) 1 and 2 JO - FASEB J VL - 26 UR - https://doi.org/10.1096/fj.11-191122 DO - 10.1096/fj.11-191122 ID - Icardi2012 ER - TY - JOUR AU - Tsai, M. H. AU - Lee, C. K. PY - 2018 DA - 2018// TI - STAT3 Cooperates With Phospholipid Scramblase 2 to Suppress Type I Interferon Response JO - Front Immunol VL - 9 UR - https://doi.org/10.3389/fimmu.2018.01886 DO - 10.3389/fimmu.2018.01886 ID - Tsai2018 ER - TY - JOUR AU - Fan, Y. AU - Mao, R. AU - Yang, J. PY - 2013 DA - 2013// TI - NF-kappaB and STAT3 signaling pathways collaboratively link inflammation to cancer JO - Protein Cell VL - 4 UR - https://doi.org/10.1007/s13238-013-2084-3 DO - 10.1007/s13238-013-2084-3 ID - Fan2013 ER - TY - JOUR AU - Taniguchi, K. AU - Karin, M. PY - 2018 DA - 2018// TI - NF-kappaB, inflammation, immunity and cancer: coming of age JO - Nat Rev Immunol VL - 18 UR - https://doi.org/10.1038/nri.2017.142 DO - 10.1038/nri.2017.142 ID - Taniguchi2018 ER - TY - JOUR AU - Lee, H. AU - Herrmann, A. AU - Deng, J. H. AU - Kujawski, M. AU - Niu, G. AU - Li, Z. PY - 2009 DA - 2009// TI - Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors JO - Cancer Cell VL - 15 UR - https://doi.org/10.1016/j.ccr.2009.02.015 DO - 10.1016/j.ccr.2009.02.015 ID - Lee2009 ER - TY - JOUR AU - Garg, B. AU - Giri, B. AU - Modi, S. AU - Sethi, V. AU - Castro, I. AU - Umland, O. PY - 2018 DA - 2018// TI - NFkappaB in Pancreatic Stellate Cells Reduces Infiltration of Tumors by Cytotoxic T Cells and Killing of Cancer Cells, via Up-regulation of CXCL12 JO - Gastroenterology. VL - 155 UR - https://doi.org/10.1053/j.gastro.2018.05.051 DO - 10.1053/j.gastro.2018.05.051 ID - Garg2018 ER - TY - JOUR AU - Saha, A. AU - Ahn, S. AU - Blando, J. AU - Su, F. AU - Kolonin, M. G. AU - DiGiovanni, J. PY - 2017 DA - 2017// TI - Proinflammatory CXCL12-CXCR4/CXCR7 Signaling Axis Drives Myc-Induced Prostate Cancer in Obese Mice JO - Cancer Res VL - 77 UR - https://doi.org/10.1158/0008-5472.CAN-17-0284 DO - 10.1158/0008-5472.CAN-17-0284 ID - Saha2017 ER - TY - JOUR AU - Shaim, H. AU - Estrov, Z. AU - Harris, D. AU - Hernandez Sanabria, M. AU - Liu, Z. AU - Ruvolo, P. PY - 2017 DA - 2017// TI - The CXCR4-STAT3-IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide JO - Front Immunol VL - 8 UR - https://doi.org/10.3389/fimmu.2017.01773 DO - 10.3389/fimmu.2017.01773 ID - Shaim2017 ER - TY - STD TI - Rebe C, Ghiringhelli F. STAT3, a Master Regulator of Anti-Tumor Immune Response. Cancers (Basel). 2019;11. ID - ref62 ER - TY - JOUR AU - Huynh, J. AU - Chand, A. AU - Gough, D. AU - Ernst, M. PY - 2019 DA - 2019// TI - Therapeutically exploiting STAT3 activity in cancer - using tissue repair as a road map JO - Nat Rev Cancer VL - 19 UR - https://doi.org/10.1038/s41568-018-0090-8 DO - 10.1038/s41568-018-0090-8 ID - Huynh2019 ER - TY - JOUR AU - Yu, H. AU - Kortylewski, M. AU - Pardoll, D. PY - 2007 DA - 2007// TI - Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment JO - Nat Rev Immunol VL - 7 UR - https://doi.org/10.1038/nri1995 DO - 10.1038/nri1995 ID - Yu2007 ER - TY - JOUR AU - Yoo, S. A. AU - Kim, M. AU - Kang, M. C. AU - Kong, J. S. AU - Kim, K. M. AU - Lee, S. PY - 2019 DA - 2019// TI - Placental growth factor regulates the generation of TH17 cells to link angiogenesis with autoimmunity JO - Nat Immunol VL - 20 UR - https://doi.org/10.1038/s41590-019-0456-4 DO - 10.1038/s41590-019-0456-4 ID - Yoo2019 ER - TY - JOUR AU - Lin, F. AU - Meng, X. AU - Guo, Y. AU - Cao, W. AU - Liu, W. AU - Xia, Q. PY - 2019 DA - 2019// TI - Epigenetic initiation of the TH17 differentiation program is promoted by Cxxc finger protein 1 JO - Sci Adv VL - 5 UR - https://doi.org/10.1126/sciadv.aax1608 DO - 10.1126/sciadv.aax1608 ID - Lin2019 ER - TY - STD TI - Mohammadpour H, MacDonald CR, Qiao G, Chen M, Dong B, Hylander BL, et al. beta2 Adrenergic receptor-mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells. J Clin Invest. 2019. ID - ref67 ER - TY - JOUR AU - Takenaka, M. C. AU - Gabriely, G. AU - Rothhammer, V. AU - Mascanfroni, I. D. AU - Wheeler, M. A. AU - Chao, C. C. PY - 2019 DA - 2019// TI - Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39 JO - Nat Neurosci VL - 22 UR - https://doi.org/10.1038/s41593-019-0370-y DO - 10.1038/s41593-019-0370-y ID - Takenaka2019 ER - TY - STD TI - Oweida AJ, Darragh L, Phan A, Binder D, Bhatia S, Mueller A, et al. STAT3 Modulation of Regulatory T Cells in Response to Radiation Therapy in Head and Neck Cancer. J Natl Cancer Inst. 2019. ID - ref69 ER - TY - JOUR AU - Chen, X. AU - Song, E. PY - 2019 DA - 2019// TI - Turning foes to friends: targeting cancer-associated fibroblasts JO - Nat Rev Drug Discov VL - 18 UR - https://doi.org/10.1038/s41573-018-0004-1 DO - 10.1038/s41573-018-0004-1 ID - Chen2019 ER - TY - JOUR AU - Albrengues, J. AU - Bertero, T. AU - Grasset, E. AU - Bonan, S. AU - Maiel, M. AU - Bourget, I. PY - 2015 DA - 2015// TI - Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts JO - Nat Commun VL - 6 UR - https://doi.org/10.1038/ncomms10204 DO - 10.1038/ncomms10204 ID - Albrengues2015 ER - TY - JOUR AU - Yang, X. AU - Lin, Y. AU - Shi, Y. AU - Li, B. AU - Liu, W. AU - Yin, W. PY - 2016 DA - 2016// TI - FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling JO - Cancer Res VL - 76 UR - https://doi.org/10.1158/0008-5472.CAN-15-2973 DO - 10.1158/0008-5472.CAN-15-2973 ID - Yang2016 ER - TY - JOUR AU - Li, X. AU - Xu, Q. AU - Wu, Y. AU - Li, J. AU - Tang, D. AU - Han, L. PY - 2014 DA - 2014// TI - A CCL2/ROS autoregulation loop is critical for cancer-associated fibroblasts-enhanced tumor growth of oral squamous cell carcinoma JO - Carcinogenesis. VL - 35 UR - https://doi.org/10.1093/carcin/bgu046 DO - 10.1093/carcin/bgu046 ID - Li2014 ER - TY - STD TI - Heichler C, Scheibe K, Schmied A, Geppert CI, Schmid B, Wirtz S, et al. STAT3 activation through IL-6/IL-11 in cancer-associated fibroblasts promotes colorectal tumour development and correlates with poor prognosis. Gut. 2019. ID - ref74 ER - TY - JOUR AU - Giovanelli, P. AU - Sandoval, T. A. AU - Cubillos-Ruiz, J. R. PY - 2019 DA - 2019// TI - Dendritic Cell Metabolism and Function in Tumors JO - Trends Immunol VL - 40 UR - https://doi.org/10.1016/j.it.2019.06.004 DO - 10.1016/j.it.2019.06.004 ID - Giovanelli2019 ER - TY - JOUR AU - Farren, M. R. AU - Carlson, L. M. AU - Netherby, C. S. AU - Lindner, I. AU - Li, P. K. AU - Gabrilovich, D. I. PY - 2014 DA - 2014// TI - Tumor-induced STAT3 signaling in myeloid cells impairs dendritic cell generation by decreasing PKCbetaII abundance JO - Sci Signal VL - 7 UR - https://doi.org/10.1126/scisignal.2004656 DO - 10.1126/scisignal.2004656 ID - Farren2014 ER - TY - JOUR AU - Calon, A. AU - Espinet, E. AU - Palomo-Ponce, S. AU - Tauriello, D. V. AU - Iglesias, M. AU - Cespedes, M. V. PY - 2012 DA - 2012// TI - Dependency of colorectal cancer on a TGF-beta-driven program in stromal cells for metastasis initiation JO - Cancer Cell VL - 22 UR - https://doi.org/10.1016/j.ccr.2012.08.013 DO - 10.1016/j.ccr.2012.08.013 ID - Calon2012 ER - TY - JOUR AU - Ohlund, D. AU - Handly-Santana, A. AU - Biffi, G. AU - Elyada, E. AU - Almeida, A. S. AU - Ponz-Sarvise, M. PY - 2017 DA - 2017// TI - Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer JO - J Exp Med VL - 214 UR - https://doi.org/10.1084/jem.20162024 DO - 10.1084/jem.20162024 ID - Ohlund2017 ER - TY - STD TI - Huang H, Zhang Y, Gallegos V, Sorrelle N, Zaid MM, Toombs J, et al. Targeting TGFbetaR2-mutant tumors exposes vulnerabilities to stromal TGFbeta blockade in pancreatic cancer. EMBO Mol Med. 2019:e10515. ID - ref79 ER - TY - JOUR AU - Ham, I. H. AU - Oh, H. J. AU - Jin, H. AU - Bae, C. A. AU - Jeon, S. M. AU - Choi, K. S. PY - 2019 DA - 2019// TI - Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer JO - Mol Cancer VL - 18 UR - https://doi.org/10.1186/s12943-019-0972-8 DO - 10.1186/s12943-019-0972-8 ID - Ham2019 ER - TY - JOUR AU - Lin, Q. AU - Ren, L. AU - Jian, M. AU - Xu, P. AU - Li, J. AU - Zheng, P. PY - 2019 DA - 2019// TI - The mechanism of the premetastatic niche facilitating colorectal cancer liver metastasis generated from myeloid-derived suppressor cells induced by the S1PR1-STAT3 signaling pathway JO - Cell Death Dis VL - 10 UR - https://doi.org/10.1038/s41419-019-1922-5 DO - 10.1038/s41419-019-1922-5 ID - Lin2019 ER - TY - JOUR AU - Cheng, J. T. AU - Deng, Y. N. AU - Yi, H. M. AU - Wang, G. Y. AU - Fu, B. S. AU - Chen, W. J. PY - 2016 DA - 2016// TI - Hepatic carcinoma-associated fibroblasts induce IDO-producing regulatory dendritic cells through IL-6-mediated STAT3 activation JO - Oncogenesis. VL - 5 UR - https://doi.org/10.1038/oncsis.2016.7 DO - 10.1038/oncsis.2016.7 ID - Cheng2016 ER - TY - JOUR AU - Nagathihalli, N. S. AU - Castellanos, J. A. AU - Shi, C. AU - Beesetty, Y. AU - Reyzer, M. L. AU - Caprioli, R. PY - 2015 DA - 2015// TI - Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer JO - Gastroenterology. VL - 149 UR - https://doi.org/10.1053/j.gastro.2015.07.058 DO - 10.1053/j.gastro.2015.07.058 ID - Nagathihalli2015 ER - TY - JOUR AU - Sanz-Moreno, V. AU - Gaggioli, C. AU - Yeo, M. AU - Albrengues, J. AU - Wallberg, F. AU - Viros, A. PY - 2011 DA - 2011// TI - ROCK and JAK1 signaling cooperate to control actomyosin contractility in tumor cells and stroma JO - Cancer Cell VL - 20 UR - https://doi.org/10.1016/j.ccr.2011.06.018 DO - 10.1016/j.ccr.2011.06.018 ID - Sanz-Moreno2011 ER - TY - JOUR AU - Gelain, A. AU - Mori, M. AU - Meneghetti, F. AU - Villa, S. PY - 2019 DA - 2019// TI - Signal Transducer and Activator of Transcription Protein 3 (STAT3): An Update on its Direct Inhibitors as Promising Anticancer Agents JO - Curr Med Chem VL - 26 UR - https://doi.org/10.2174/0929867325666180719122729 DO - 10.2174/0929867325666180719122729 ID - Gelain2019 ER - TY - JOUR AU - Beebe, J. D. AU - Liu, J. Y. AU - Zhang, J. T. PY - 2018 DA - 2018// TI - Two decades of research in discovery of anticancer drugs targeting STAT3, how close are we? JO - Pharmacol Ther VL - 191 UR - https://doi.org/10.1016/j.pharmthera.2018.06.006 DO - 10.1016/j.pharmthera.2018.06.006 ID - Beebe2018 ER - TY - JOUR AU - Nagel-Wolfrum, K. AU - Buerger, C. AU - Wittig, I. AU - Butz, K. AU - Hoppe-Seyler, F. AU - Groner, B. PY - 2004 DA - 2004// TI - The interaction of specific peptide aptamers with the DNA binding domain and the dimerization domain of the transcription factor Stat3 inhibits transactivation and induces apoptosis in tumor cells JO - Mol Cancer Res VL - 2 ID - Nagel-Wolfrum2004 ER - TY - JOUR AU - Miccoli, A. AU - Dhiani, B. A. AU - Mehellou, Y. PY - 2019 DA - 2019// TI - Phosphotyrosine prodrugs: design, synthesis and anti-STAT3 activity of ISS-610 aryloxy triester phosphoramidate prodrugs JO - Medchemcomm. VL - 10 UR - https://doi.org/10.1039/C8MD00244D DO - 10.1039/C8MD00244D ID - Miccoli2019 ER - TY - JOUR AU - Turkson, J. AU - Ryan, D. AU - Kim, J. S. AU - Zhang, Y. AU - Chen, Z. AU - Haura, E. PY - 2001 DA - 2001// TI - Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation JO - J Biol Chem VL - 276 UR - https://doi.org/10.1074/jbc.M107527200 DO - 10.1074/jbc.M107527200 ID - Turkson2001 ER - TY - JOUR AU - Ji, P. AU - Xu, X. AU - Ma, S. AU - Fan, J. AU - Zhou, Q. AU - Mao, X. PY - 2015 DA - 2015// TI - Novel 2-Carbonylbenzo [b] thiophene 1,1-Dioxide Derivatives as Potent Inhibitors of STAT3 Signaling Pathway JO - ACS Med Chem Lett VL - 6 UR - https://doi.org/10.1021/acsmedchemlett.5b00228 DO - 10.1021/acsmedchemlett.5b00228 ID - Ji2015 ER - TY - JOUR AU - Lin, L. AU - Hutzen, B. AU - Zuo, M. AU - Ball, S. AU - Deangelis, S. AU - Foust, E. PY - 2010 DA - 2010// TI - Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells JO - Cancer Res VL - 70 UR - https://doi.org/10.1158/0008-5472.CAN-09-2468 DO - 10.1158/0008-5472.CAN-09-2468 ID - Lin2010 ER - TY - JOUR AU - Li, Z. AU - Zhu, T. AU - Xu, Y. AU - Wu, C. AU - Chen, J. AU - Ren, Y. PY - 2019 DA - 2019// TI - A novel STAT3 inhibitor, HJC0152, exerts potent antitumor activity in glioblastoma JO - Am J Cancer Res VL - 9 ID - Li2019 ER - TY - JOUR AU - Liu, Z. AU - Wang, H. AU - Guan, L. AU - Lai, C. AU - Yu, W. AU - Lai, M. PY - 2020 DA - 2020// TI - LL1, a novel and highly selective STAT3 inhibitor, displays anti-colorectal cancer activities in vitro and in vivo JO - Br J Pharmacol VL - 177 UR - https://doi.org/10.1111/bph.14863 DO - 10.1111/bph.14863 ID - Liu2020 ER - TY - JOUR AU - Fuh, B. AU - Sobo, M. AU - Cen, L. AU - Josiah, D. AU - Hutzen, B. AU - Cisek, K. PY - 2009 DA - 2009// TI - LLL-3 inhibits STAT3 activity, suppresses glioblastoma cell growth and prolongs survival in a mouse glioblastoma model JO - Br J Cancer VL - 100 UR - https://doi.org/10.1038/sj.bjc.6604793 DO - 10.1038/sj.bjc.6604793 ID - Fuh2009 ER - TY - JOUR AU - Zuo, M. AU - Li, C. AU - Lin, J. AU - Javle, M. PY - 2015 DA - 2015// TI - LLL12, a novel small inhibitor targeting STAT3 for hepatocellular carcinoma therapy JO - Oncotarget. VL - 6 UR - https://doi.org/10.18632/oncotarget.3458 DO - 10.18632/oncotarget.3458 ID - Zuo2015 ER - TY - JOUR AU - Wang, H. AU - Liu, Z. AU - Guan, L. AU - Li, J. AU - Chen, S. AU - Yu, W. PY - 2020 DA - 2020// TI - LYW-6, a novel cryptotanshinone derived STAT3 targeting inhibitor, suppresses colorectal cancer growth and metastasis JO - Pharmacol Res VL - 153 UR - https://doi.org/10.1016/j.phrs.2020.104661 DO - 10.1016/j.phrs.2020.104661 ID - Wang2020 ER - TY - JOUR AU - Kim, L. H. AU - Khadka, S. AU - Shin, J. A. AU - Jung, J. Y. AU - Ryu, M. H. AU - Yu, H. J. PY - 2017 DA - 2017// TI - Nitidine chloride acts as an apoptosis inducer in human oral cancer cells and a nude mouse xenograft model via inhibition of STAT3 JO - Oncotarget. VL - 8 UR - https://doi.org/10.18632/oncotarget.20444 DO - 10.18632/oncotarget.20444 ID - Kim2017 ER - TY - JOUR AU - Bai, L. AU - Zhou, H. AU - Xu, R. AU - Zhao, Y. AU - Chinnaswamy, K. AU - McEachern, D. PY - 2019 DA - 2019// TI - A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo JO - Cancer Cell VL - 36 UR - https://doi.org/10.1016/j.ccell.2019.10.002 DO - 10.1016/j.ccell.2019.10.002 ID - Bai2019 ER - TY - JOUR AU - Schust, J. AU - Sperl, B. AU - Hollis, A. AU - Mayer, T. U. AU - Berg, T. PY - 2006 DA - 2006// TI - Stattic: a small-molecule inhibitor of STAT3 activation and dimerization JO - Chem Biol VL - 13 UR - https://doi.org/10.1016/j.chembiol.2006.09.018 DO - 10.1016/j.chembiol.2006.09.018 ID - Schust2006 ER - TY - JOUR AU - Akiyama, Y. AU - Nonomura, C. AU - Ashizawa, T. AU - Iizuka, A. AU - Kondou, R. AU - Miyata, H. PY - 2017 DA - 2017// TI - The anti-tumor activity of the STAT3 inhibitor STX-0119 occurs via promotion of tumor-infiltrating lymphocyte accumulation in temozolomide-resistant glioblastoma cell line JO - Immunol Lett VL - 190 UR - https://doi.org/10.1016/j.imlet.2017.07.005 DO - 10.1016/j.imlet.2017.07.005 ID - Akiyama2017 ER - TY - JOUR AU - Soleimani, A. H. AU - Garg, S. M. AU - Paiva, I. M. AU - Vakili, M. R. AU - Alshareef, A. AU - Huang, Y. H. PY - 2017 DA - 2017// TI - Micellar nano-carriers for the delivery of STAT3 dimerization inhibitors to melanoma JO - Drug Deliv Transl Res VL - 7 UR - https://doi.org/10.1007/s13346-017-0369-4 DO - 10.1007/s13346-017-0369-4 ID - Soleimani2017 ER - TY - JOUR AU - Siddiquee, K. AU - Zhang, S. AU - Guida, W. C. AU - Blaskovich, M. A. AU - Greedy, B. AU - Lawrence, H. R. PY - 2007 DA - 2007// TI - Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity JO - Proc Natl Acad Sci U S A VL - 104 UR - https://doi.org/10.1073/pnas.0609757104 DO - 10.1073/pnas.0609757104 ID - Siddiquee2007 ER - TY - JOUR AU - Turkson, J. AU - Zhang, S. AU - Palmer, J. AU - Kay, H. AU - Stanko, J. AU - Mora, L. B. PY - 2004 DA - 2004// TI - Inhibition of constitutive signal transducer and activator of transcription 3 activation by novel platinum complexes with potent antitumor activity JO - Mol Cancer Ther VL - 3 ID - Turkson2004 ER - TY - JOUR AU - Buettner, R. AU - Corzano, R. AU - Rashid, R. AU - Lin, J. AU - Senthil, M. AU - Hedvat, M. PY - 2011 DA - 2011// TI - Alkylation of cysteine 468 in Stat3 defines a novel site for therapeutic development JO - ACS Chem Biol VL - 6 UR - https://doi.org/10.1021/cb100253e DO - 10.1021/cb100253e ID - Buettner2011 ER - TY - JOUR AU - Escobar, Z. AU - Bjartell, A. AU - Canesin, G. AU - Evans-Axelsson, S. AU - Sterner, O. AU - Hellsten, R. PY - 2016 DA - 2016// TI - Preclinical Characterization of 3beta-(N-Acetyl l-cysteine methyl ester)-2abeta,3-dihydrogaliellalactone (GPA512), a Prodrug of a Direct STAT3 Inhibitor for the Treatment of Prostate Cancer JO - J Med Chem VL - 59 UR - https://doi.org/10.1021/acs.jmedchem.5b01814 DO - 10.1021/acs.jmedchem.5b01814 ID - Escobar2016 ER - TY - JOUR AU - Son, D. J. AU - Zheng, J. AU - Jung, Y. Y. AU - Hwang, C. J. AU - Lee, H. P. AU - Woo, J. R. PY - 2017 DA - 2017// TI - MMPP Attenuates Non-Small Cell Lung Cancer Growth by Inhibiting the STAT3 DNA-Binding Activity via Direct Binding to the STAT3 DNA-Binding Domain JO - Theranostics. VL - 7 UR - https://doi.org/10.7150/thno.18630 DO - 10.7150/thno.18630 ID - Son2017 ER - TY - JOUR AU - Huang, W. AU - Dong, Z. AU - Chen, Y. AU - Wang, F. AU - Wang, C. J. AU - Peng, H. PY - 2016 DA - 2016// TI - Small-molecule inhibitors targeting the DNA-binding domain of STAT3 suppress tumor growth, metastasis and STAT3 target gene expression in vivo JO - Oncogene. VL - 35 UR - https://doi.org/10.1038/onc.2015.215 DO - 10.1038/onc.2015.215 ID - Huang2016 ER - TY - JOUR AU - Souissi, I. AU - Ladam, P. AU - Cognet, J. A. AU - Coquil, S. AU - Varin-Blank, N. AU - Baran-Marszak, F. PY - 2012 DA - 2012// TI - A STAT3-inhibitory hairpin decoy oligodeoxynucleotide discriminates between STAT1 and STAT3 and induces death in a human colon carcinoma cell line JO - Mol Cancer VL - 11 UR - https://doi.org/10.1186/1476-4598-11-12 DO - 10.1186/1476-4598-11-12 ID - Souissi2012 ER - TY - JOUR AU - Koppikar, P. AU - Abdel-Wahab, O. AU - Hedvat, C. AU - Marubayashi, S. AU - Patel, J. AU - Goel, A. PY - 2010 DA - 2010// TI - Efficacy of the JAK2 inhibitor INCB16562 in a murine model of MPLW515L-induced thrombocytosis and myelofibrosis JO - Blood. VL - 115 UR - https://doi.org/10.1182/blood-2009-04-218842 DO - 10.1182/blood-2009-04-218842 ID - Koppikar2010 ER - TY - JOUR AU - Lo, M. C. AU - Peterson, L. F. AU - Yan, M. AU - Cong, X. AU - Hickman, J. H. AU - Dekelver, R. C. PY - 2013 DA - 2013// TI - JAK inhibitors suppress t(8;21) fusion protein-induced leukemia JO - Leukemia. VL - 27 UR - https://doi.org/10.1038/leu.2013.197 DO - 10.1038/leu.2013.197 ID - Lo2013 ER - TY - JOUR AU - Lu, X. AU - Zhang, T. AU - Zhu, S. J. AU - Xun, Q. AU - Tong, L. AU - Hu, X. PY - 2018 DA - 2018// TI - Discovery of JND3229 as a New EGFR(C797S) Mutant Inhibitor with In Vivo Monodrug Efficacy JO - ACS Med Chem Lett VL - 9 UR - https://doi.org/10.1021/acsmedchemlett.8b00373 DO - 10.1021/acsmedchemlett.8b00373 ID - Lu2018 ER - TY - JOUR AU - Holmstrom, T. H. AU - Moilanen, A. M. AU - Ikonen, T. AU - Bjorkman, M. L. AU - Linnanen, T. AU - Wohlfahrt, G. PY - 2019 DA - 2019// TI - ODM-203, a Selective Inhibitor of FGFR and VEGFR, Shows Strong Antitumor Activity, and Induces Antitumor Immunity JO - Mol Cancer Ther VL - 18 UR - https://doi.org/10.1158/1535-7163.MCT-18-0204 DO - 10.1158/1535-7163.MCT-18-0204 ID - Holmstrom2019 ER - TY - JOUR AU - Pei, J. AU - Zhang, Y. AU - Luo, Q. AU - Zheng, W. AU - Li, W. AU - Zeng, X. PY - 2019 DA - 2019// TI - STAT3 inhibition enhances CDN-induced STING signaling and antitumor immunity JO - Cancer Lett VL - 450 UR - https://doi.org/10.1016/j.canlet.2019.02.029 DO - 10.1016/j.canlet.2019.02.029 ID - Pei2019 ER - TY - JOUR AU - Lu, C. AU - Talukder, A. AU - Savage, N. M. AU - Singh, N. AU - Liu, K. PY - 2017 DA - 2017// TI - JAK-STAT-mediated chronic inflammation impairs cytotoxic T lymphocyte activation to decrease anti-PD-1 immunotherapy efficacy in pancreatic cancer JO - Oncoimmunology. VL - 6 UR - https://doi.org/10.1080/2162402X.2017.1291106 DO - 10.1080/2162402X.2017.1291106 ID - Lu2017 ER - TY - JOUR AU - Yu, G. T. AU - Mao, L. AU - Wu, L. AU - Deng, W. W. AU - Bu, L. L. AU - Liu, J. F. PY - 2018 DA - 2018// TI - Inhibition of SRC family kinases facilitates anti-CTLA4 immunotherapy in head and neck squamous cell carcinoma JO - Cell Mol Life Sci VL - 75 UR - https://doi.org/10.1007/s00018-018-2863-3 DO - 10.1007/s00018-018-2863-3 ID - Yu2018 ER - TY - JOUR AU - Yang, H. AU - Lee, W. S. AU - Kong, S. J. AU - Kim, C. G. AU - Kim, J. H. AU - Chang, S. K. PY - 2019 DA - 2019// TI - STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade JO - J Clin Invest VL - 130 UR - https://doi.org/10.1172/JCI125413 DO - 10.1172/JCI125413 ID - Yang2019 ER - TY - JOUR AU - Jonker, D. J. AU - Nott, L. AU - Yoshino, T. AU - Gill, S. AU - Shapiro, J. AU - Ohtsu, A. PY - 2018 DA - 2018// TI - Napabucasin versus placebo in refractory advanced colorectal cancer: a randomised phase 3 trial JO - Lancet Gastroenterol Hepatol VL - 3 UR - https://doi.org/10.1016/S2468-1253(18)30009-8 DO - 10.1016/S2468-1253(18)30009-8 ID - Jonker2018 ER - TY - JOUR AU - Reilley, M. J. AU - McCoon, P. AU - Cook, C. AU - Lyne, P. AU - Kurzrock, R. AU - Kim, Y. PY - 2018 DA - 2018// TI - STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial JO - J Immunother Cancer VL - 6 UR - https://doi.org/10.1186/s40425-018-0436-5 DO - 10.1186/s40425-018-0436-5 ID - Reilley2018 ER - TY - JOUR AU - Sen, M. AU - Thomas, S. M. AU - Kim, S. AU - Yeh, J. I. AU - Ferris, R. L. AU - Johnson, J. T. PY - 2012 DA - 2012// TI - First-in-human trial of a STAT3 decoy oligonucleotide in head and neck tumors: implications for cancer therapy JO - Cancer Discov VL - 2 UR - https://doi.org/10.1158/2159-8290.CD-12-0191 DO - 10.1158/2159-8290.CD-12-0191 ID - Sen2012 ER - TY - JOUR AU - Gupta, V. AU - Mesa, R. A. AU - Deininger, M. W. AU - Rivera, C. E. AU - Sirhan, S. AU - Brachmann, C. B. PY - 2017 DA - 2017// TI - A phase 1/2, open-label study evaluating twice-daily administration of momelotinib in myelofibrosis JO - Haematologica. VL - 102 UR - https://doi.org/10.3324/haematol.2016.148924 DO - 10.3324/haematol.2016.148924 ID - Gupta2017 ER - TY - JOUR AU - Berdeja, J. AU - Palandri, F. AU - Baer, M. R. AU - Quick, D. AU - Kiladjian, J. J. AU - Martinelli, G. PY - 2018 DA - 2018// TI - Phase 2 study of gandotinib (LY2784544) in patients with myeloproliferative neoplasms JO - Leuk Res VL - 71 UR - https://doi.org/10.1016/j.leukres.2018.06.014 DO - 10.1016/j.leukres.2018.06.014 ID - Berdeja2018 ER - TY - JOUR AU - Mascarenhas, J. AU - Hoffman, R. AU - Talpaz, M. AU - Gerds, A. T. AU - Stein, B. AU - Gupta, V. PY - 2018 DA - 2018// TI - Pacritinib vs Best Available Therapy, Including Ruxolitinib, in Patients With Myelofibrosis: A Randomized Clinical Trial JO - JAMA Oncol VL - 4 UR - https://doi.org/10.1001/jamaoncol.2017.5818 DO - 10.1001/jamaoncol.2017.5818 ID - Mascarenhas2018 ER - TY - JOUR AU - Kim, D. W. AU - Saussele, S. AU - Williams, L. A. AU - Mohamed, H. AU - Rong, Y. AU - Zyczynski, T. PY - 2018 DA - 2018// TI - Outcomes of switching to dasatinib after imatinib-related low-grade adverse events in patients with chronic myeloid leukemia in chronic phase: the DASPERSE study JO - Ann Hematol VL - 97 UR - https://doi.org/10.1007/s00277-018-3295-8 DO - 10.1007/s00277-018-3295-8 ID - Kim2018 ER - TY - JOUR AU - Antonarakis, E. S. AU - Heath, E. I. AU - Posadas, E. M. AU - Yu, E. Y. AU - Harrison, M. R. AU - Bruce, J. Y. PY - 2013 DA - 2013// TI - A phase 2 study of KX2-391, an oral inhibitor of Src kinase and tubulin polymerization, in men with bone-metastatic castration-resistant prostate cancer JO - Cancer Chemother Pharmacol VL - 71 UR - https://doi.org/10.1007/s00280-013-2079-z DO - 10.1007/s00280-013-2079-z ID - Antonarakis2013 ER - TY - JOUR AU - Finn, R. S. AU - Qin, S. AU - Ikeda, M. AU - Galle, P. R. AU - Ducreux, M. AU - Kim, T. Y. PY - 2020 DA - 2020// TI - Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma JO - N Engl J Med VL - 382 UR - https://doi.org/10.1056/NEJMoa1915745 DO - 10.1056/NEJMoa1915745 ID - Finn2020 ER - TY - JOUR AU - D'Angelo, S. P. AU - Shoushtari, A. N. AU - Keohan, M. L. AU - Dickson, M. A. AU - Gounder, M. M. AU - Chi, P. PY - 2017 DA - 2017// TI - Combined KIT and CTLA-4 Blockade in Patients with Refractory GIST and Other Advanced Sarcomas: A Phase Ib Study of Dasatinib plus Ipilimumab JO - Clin Cancer Res VL - 23 UR - https://doi.org/10.1158/1078-0432.CCR-16-2349 DO - 10.1158/1078-0432.CCR-16-2349 ID - D'Angelo2017 ER - TY - JOUR AU - Turkson, J. AU - Kim, J. S. AU - Zhang, S. AU - Yuan, J. AU - Huang, M. AU - Glenn, M. PY - 2004 DA - 2004// TI - Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activity JO - Mol Cancer Ther VL - 3 ID - Turkson2004 ER - TY - JOUR AU - Lai, A. C. AU - Crews, C. M. PY - 2017 DA - 2017// TI - Induced protein degradation: an emerging drug discovery paradigm JO - Nat Rev Drug Discov VL - 16 UR - https://doi.org/10.1038/nrd.2016.211 DO - 10.1038/nrd.2016.211 ID - Lai2017 ER - TY - JOUR AU - Winter, G. E. AU - Buckley, D. L. AU - Paulk, J. AU - Roberts, J. M. AU - Souza, A. AU - Dhe-Paganon, S. PY - 2015 DA - 2015// TI - DRUG DEVELOPMENT. Phthalimide conjugation as a strategy for in vivo target protein degradation JO - Science. VL - 348 UR - https://doi.org/10.1126/science.aab1433 DO - 10.1126/science.aab1433 ID - Winter2015 ER - TY - JOUR AU - Lai, A. C. AU - Toure, M. AU - Hellerschmied, D. AU - Salami, J. AU - Jaime-Figueroa, S. AU - Ko, E. PY - 2016 DA - 2016// TI - Modular PROTAC Design for the Degradation of Oncogenic BCR-ABL JO - Angew Chem Int Ed Eng VL - 55 UR - https://doi.org/10.1002/anie.201507634 DO - 10.1002/anie.201507634 ID - Lai2016 ER - TY - JOUR AU - Burslem, G. M. AU - Smith, B. E. AU - Lai, A. C. AU - Jaime-Figueroa, S. AU - McQuaid, D. C. AU - Bondeson, D. P. PY - 2018 DA - 2018// TI - The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study JO - Cell Chem Biol VL - 25 UR - https://doi.org/10.1016/j.chembiol.2017.09.009 DO - 10.1016/j.chembiol.2017.09.009 ID - Burslem2018 ER - TY - JOUR AU - Khan, S. AU - Zhang, X. AU - Lv, D. AU - Zhang, Q. AU - He, Y. AU - Zhang, P. PY - 2019 DA - 2019// TI - A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity JO - Nat Med VL - 25 UR - https://doi.org/10.1038/s41591-019-0668-z DO - 10.1038/s41591-019-0668-z ID - Khan2019 ER - TY - JOUR AU - Njatcha, C. AU - Farooqui, M. AU - Kornberg, A. AU - Johnson, D. E. AU - Grandis, J. R. AU - Siegfried, J. M. PY - 2018 DA - 2018// TI - STAT3 Cyclic Decoy Demonstrates Robust Antitumor Effects in Non-Small Cell Lung Cancer JO - Mol Cancer Ther VL - 17 UR - https://doi.org/10.1158/1535-7163.MCT-17-1194 DO - 10.1158/1535-7163.MCT-17-1194 ID - Njatcha2018 ER - TY - JOUR AU - Hong, D. AU - Kurzrock, R. AU - Kim, Y. AU - Woessner, R. AU - Younes, A. AU - Nemunaitis, J. PY - 2015 DA - 2015// TI - AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer JO - Sci Transl Med VL - 7 UR - https://doi.org/10.1126/scitranslmed.aac5272 DO - 10.1126/scitranslmed.aac5272 ID - Hong2015 ER - TY - JOUR AU - Odate, S. AU - Veschi, V. AU - Yan, S. AU - Lam, N. AU - Woessner, R. AU - Thiele, C. J. PY - 2017 DA - 2017// TI - Inhibition of STAT3 with the Generation 2.5 Antisense Oligonucleotide, AZD9150, Decreases Neuroblastoma Tumorigenicity and Increases Chemosensitivity JO - Clin Cancer Res VL - 23 UR - https://doi.org/10.1158/1078-0432.CCR-16-1317 DO - 10.1158/1078-0432.CCR-16-1317 ID - Odate2017 ER - TY - JOUR AU - Shastri, A. AU - Choudhary, G. AU - Teixeira, M. AU - Gordon-Mitchell, S. AU - Ramachandra, N. AU - Bernard, L. PY - 2018 DA - 2018// TI - Antisense STAT3 inhibitor decreases viability of myelodysplastic and leukemic stem cells JO - J Clin Invest VL - 128 UR - https://doi.org/10.1172/JCI120156 DO - 10.1172/JCI120156 ID - Shastri2018 ER - TY - JOUR AU - Zhou, J. AU - Rossi, J. PY - 2017 DA - 2017// TI - Aptamers as targeted therapeutics: current potential and challenges JO - Nat Rev Drug Discov VL - 16 UR - https://doi.org/10.1038/nrd.2016.199 DO - 10.1038/nrd.2016.199 ID - Zhou2017 ER - TY - JOUR AU - Esposito, C. L. AU - Nuzzo, S. AU - Catuogno, S. AU - Romano, S. AU - Nigris, F. AU - Franciscis, V. PY - 2018 DA - 2018// TI - STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma JO - Mol Ther Nucleic Acids VL - 10 UR - https://doi.org/10.1016/j.omtn.2017.12.021 DO - 10.1016/j.omtn.2017.12.021 ID - Esposito2018 ER - TY - JOUR AU - Yoon, S. AU - Wu, X. AU - Armstrong, B. AU - Habib, N. AU - Rossi, J. J. PY - 2019 DA - 2019// TI - An RNA Aptamer Targeting the Receptor Tyrosine Kinase PDGFRalpha Induces Anti-tumor Effects through STAT3 and p53 in Glioblastoma JO - Mol Ther Nucleic Acids VL - 14 UR - https://doi.org/10.1016/j.omtn.2018.11.012 DO - 10.1016/j.omtn.2018.11.012 ID - Yoon2019 ER - TY - JOUR AU - Heppler, L. N. AU - Frank, D. A. PY - 2017 DA - 2017// TI - Targeting Oncogenic Transcription Factors: Therapeutic Implications of Endogenous STAT Inhibitors JO - Trends Cancer VL - 3 UR - https://doi.org/10.1016/j.trecan.2017.10.004 DO - 10.1016/j.trecan.2017.10.004 ID - Heppler2017 ER - TY - JOUR AU - Khan, M. W. AU - Saadalla, A. AU - Ewida, A. H. AU - Al-Katranji, K. AU - Al-Saoudi, G. AU - Giaccone, Z. T. PY - 2018 DA - 2018// TI - The STAT3 inhibitor pyrimethamine displays anti-cancer and immune stimulatory effects in murine models of breast cancer JO - Cancer Immunol Immunother VL - 67 UR - https://doi.org/10.1007/s00262-017-2057-0 DO - 10.1007/s00262-017-2057-0 ID - Khan2018 ER - TY - JOUR AU - Li, H. AU - Liu, A. AU - Zhao, Z. AU - Xu, Y. AU - Lin, J. AU - Jou, D. PY - 2011 DA - 2011// TI - Fragment-based drug design and drug repositioning using multiple ligand simultaneous docking (MLSD): identifying celecoxib and template compounds as novel inhibitors of signal transducer and activator of transcription 3 (STAT3) JO - J Med Chem VL - 54 UR - https://doi.org/10.1021/jm101330h DO - 10.1021/jm101330h ID - Li2011 ER - TY - STD TI - Huang R, Jing X, Huang X, Pan Y, Fang Y, Liang G, et al. Bifunctional Naphthoquinone Aromatic Amide-Oxime Derivatives Exert Combined Immunotherapeutic and Antitumor Effects through Simultaneous Targeting of Indoleamine-2,3-dioxygenase and Signal Transducer and Activator of Transcription 3. J Med Chem. 2020. ID - ref143 ER - TY - JOUR AU - Buchert, M. AU - Burns, C. J. AU - Ernst, M. PY - 2016 DA - 2016// TI - Targeting JAK kinase in solid tumors: emerging opportunities and challenges JO - Oncogene. VL - 35 UR - https://doi.org/10.1038/onc.2015.150 DO - 10.1038/onc.2015.150 ID - Buchert2016 ER - TY - JOUR AU - Kang, S. AU - Tanaka, T. AU - Narazaki, M. AU - Kishimoto, T. PY - 2019 DA - 2019// TI - Targeting Interleukin-6 Signaling in Clinic JO - Immunity. VL - 50 UR - https://doi.org/10.1016/j.immuni.2019.03.026 DO - 10.1016/j.immuni.2019.03.026 ID - Kang2019 ER - TY - JOUR AU - Liu, L. AU - Nam, S. AU - Tian, Y. AU - Yang, F. AU - Wu, J. AU - Wang, Y. PY - 2011 DA - 2011// TI - 6-Bromoindirubin-3'-oxime inhibits JAK/STAT3 signaling and induces apoptosis of human melanoma cells JO - Cancer Res VL - 71 UR - https://doi.org/10.1158/0008-5472.CAN-10-3852 DO - 10.1158/0008-5472.CAN-10-3852 ID - Liu2011 ER - TY - JOUR AU - Tian, Y. AU - Nam, S. AU - Liu, L. AU - Yakushijin, F. AU - Yakushijin, K. AU - Buettner, R. PY - 2012 DA - 2012// TI - Spirooxindole derivative SOID-8 induces apoptosis associated with inhibition of JAK2/STAT3 signaling in melanoma cells JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0049306 DO - 10.1371/journal.pone.0049306 ID - Tian2012 ER - TY - JOUR AU - Wen, W. AU - Wu, J. AU - Liu, L. AU - Tian, Y. AU - Buettner, R. AU - Hsieh, M. Y. PY - 2015 DA - 2015// TI - Synergistic anti-tumor effect of combined inhibition of EGFR and JAK/STAT3 pathways in human ovarian cancer JO - Mol Cancer VL - 14 UR - https://doi.org/10.1186/s12943-015-0366-5 DO - 10.1186/s12943-015-0366-5 ID - Wen2015 ER - TY - JOUR AU - Zhang, Q. AU - Liu, R. X. AU - Chan, K. W. AU - Hu, J. AU - Zhang, J. AU - Wei, L. PY - 2019 DA - 2019// TI - Exosomal transfer of p-STAT3 promotes acquired 5-FU resistance in colorectal cancer cells JO - J Exp Clin Cancer Res VL - 38 UR - https://doi.org/10.1186/s13046-019-1314-9 DO - 10.1186/s13046-019-1314-9 ID - Zhang2019 ER - TY - STD TI - Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367. ID - ref150 ER - TY - JOUR AU - Xu, H. AU - Du, X. AU - Xu, J. AU - Zhang, Y. AU - Tian, Y. AU - Liu, G. PY - 2020 DA - 2020// TI - Pancreatic beta cell microRNA-26a alleviates type 2 diabetes by improving peripheral insulin sensitivity and preserving beta cell function JO - PLoS Biol VL - 18 UR - https://doi.org/10.1371/journal.pbio.3000603 DO - 10.1371/journal.pbio.3000603 ID - Xu2020 ER - TY - JOUR AU - June, C. H. AU - O'Connor, R. S. AU - Kawalekar, O. U. AU - Ghassemi, S. AU - Milone, M. C. PY - 2018 DA - 2018// TI - CAR T cell immunotherapy for human cancer JO - Science. VL - 359 UR - https://doi.org/10.1126/science.aar6711 DO - 10.1126/science.aar6711 ID - June2018 ER - TY - STD TI - Kennedy LB, Salama AKS. A review of cancer immunotherapy toxicity. CA Cancer J Clin. 2020. ID - ref153 ER - TY - STD TI - O'Reilly EM, Oh DY, Dhani N, Renouf DJ, Lee MA, Sun W, et al. Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma: A Phase 2 Randomized Clinical Trial. JAMA Oncol. 2019. ID - ref154 ER - TY - JOUR AU - Zhou, Y. AU - Fei, M. AU - Zhang, G. AU - Liang, W. C. AU - Lin, W. AU - Wu, Y. PY - 2020 DA - 2020// TI - Blockade of the Phagocytic Receptor MerTK on Tumor-Associated Macrophages Enhances P2X7R-Dependent STING Activation by Tumor-Derived cGAMP JO - Immunity. VL - 52 UR - https://doi.org/10.1016/j.immuni.2020.01.014 DO - 10.1016/j.immuni.2020.01.014 ID - Zhou2020 ER - TY - JOUR AU - Hellmann, M. D. AU - Paz-Ares, L. AU - Bernabe Caro, R. AU - Zurawski, B. AU - Kim, S. W. AU - Carcereny Costa, E. PY - 2019 DA - 2019// TI - Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer JO - N Engl J Med VL - 381 UR - https://doi.org/10.1056/NEJMoa1910231 DO - 10.1056/NEJMoa1910231 ID - Hellmann2019 ER - TY - JOUR AU - Atsaves, V. AU - Tsesmetzis, N. AU - Chioureas, D. AU - Kis, L. AU - Leventaki, V. AU - Drakos, E. PY - 2017 DA - 2017// TI - PD-L1 is commonly expressed and transcriptionally regulated by STAT3 and MYC in ALK-negative anaplastic large-cell lymphoma JO - Leukemia. VL - 31 UR - https://doi.org/10.1038/leu.2017.103 DO - 10.1038/leu.2017.103 ID - Atsaves2017 ER - TY - JOUR AU - Song, T. L. AU - Nairismagi, M. L. AU - Laurensia, Y. AU - Lim, J. Q. AU - Tan, J. AU - Li, Z. M. PY - 2018 DA - 2018// TI - Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma JO - Blood. VL - 132 UR - https://doi.org/10.1182/blood-2018-01-829424 DO - 10.1182/blood-2018-01-829424 ID - Song2018 ER - TY - JOUR AU - Garcia-Diaz, A. AU - Shin, D. S. AU - Moreno, B. H. AU - Saco, J. AU - Escuin-Ordinas, H. AU - Rodriguez, G. A. PY - 2017 DA - 2017// TI - Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression JO - Cell Rep VL - 19 UR - https://doi.org/10.1016/j.celrep.2017.04.031 DO - 10.1016/j.celrep.2017.04.031 ID - Garcia-Diaz2017 ER - TY - JOUR AU - Yoyen-Ermis, D. AU - Tunali, G. AU - Tavukcuoglu, E. AU - Horzum, U. AU - Ozkazanc, D. AU - Sutlu, T. PY - 2019 DA - 2019// TI - Myeloid maturation potentiates STAT3-mediated atypical IFN-gamma signaling and upregulation of PD-1 ligands in AML and MDS JO - Sci Rep VL - 9 UR - https://doi.org/10.1038/s41598-019-48256-4 DO - 10.1038/s41598-019-48256-4 ID - Yoyen-Ermis2019 ER - TY - JOUR AU - Herrmann, A. AU - Lahtz, C. AU - Nagao, T. AU - Song, J. Y. AU - Chan, W. C. AU - Lee, H. PY - 2017 DA - 2017// TI - CTLA4 Promotes Tyk2-STAT3-Dependent B-cell Oncogenicity JO - Cancer Res VL - 77 UR - https://doi.org/10.1158/0008-5472.CAN-16-0342 DO - 10.1158/0008-5472.CAN-16-0342 ID - Herrmann2017 ER - TY - JOUR AU - Hsu, P. AU - Santner-Nanan, B. AU - Hu, M. AU - Skarratt, K. AU - Lee, C. H. AU - Stormon, M. PY - 2015 DA - 2015// TI - IL-10 Potentiates Differentiation of Human Induced Regulatory T Cells via STAT3 and Foxo1 JO - J Immunol VL - 195 UR - https://doi.org/10.4049/jimmunol.1402898 DO - 10.4049/jimmunol.1402898 ID - Hsu2015 ER - TY - JOUR AU - Keremu, A. AU - Aimaiti, A. AU - Liang, Z. AU - Zou, X. PY - 2019 DA - 2019// TI - Role of the HDAC6/STAT3 pathway in regulating PD-L1 expression in osteosarcoma cell lines JO - Cancer Chemother Pharmacol VL - 83 UR - https://doi.org/10.1007/s00280-018-3721-6 DO - 10.1007/s00280-018-3721-6 ID - Keremu2019 ER - TY - STD TI - Celada LJ, Kropski JA, Herazo-Maya JD, Luo W, Creecy A, Abad AT, et al. PD-1 up-regulation on CD4(+) T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-beta1 production. Sci Transl Med. 2018;10. ID - ref164 ER - TY - JOUR AU - Celada, L. J. AU - Rotsinger, J. E. AU - Young, A. AU - Shaginurova, G. AU - Shelton, D. AU - Hawkins, C. PY - 2017 DA - 2017// TI - Programmed Death-1 Inhibition of Phosphatidylinositol 3-Kinase/AKT/Mechanistic Target of Rapamycin Signaling Impairs Sarcoidosis CD4(+) T Cell Proliferation JO - Am J Respir Cell Mol Biol VL - 56 UR - https://doi.org/10.1165/rcmb.2016-0037OC DO - 10.1165/rcmb.2016-0037OC ID - Celada2017 ER - TY - JOUR AU - Krasilnikov, M. AU - Ivanov, V. N. AU - Dong, J. AU - Ronai, Z. PY - 2003 DA - 2003// TI - ERK and PI3K negatively regulate STAT-transcriptional activities in human melanoma cells: implications towards sensitization to apoptosis JO - Oncogene. VL - 22 UR - https://doi.org/10.1038/sj.onc.1206598 DO - 10.1038/sj.onc.1206598 ID - Krasilnikov2003 ER - TY - JOUR AU - Mace, T. A. AU - Shakya, R. AU - Pitarresi, J. R. AU - Swanson, B. AU - McQuinn, C. W. AU - Loftus, S. PY - 2018 DA - 2018// TI - IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer JO - Gut. VL - 67 UR - https://doi.org/10.1136/gutjnl-2016-311585 DO - 10.1136/gutjnl-2016-311585 ID - Mace2018 ER - TY - JOUR AU - Liu, H. AU - Shen, J. AU - Lu, K. PY - 2017 DA - 2017// TI - IL-6 and PD-L1 blockade combination inhibits hepatocellular carcinoma cancer development in mouse model JO - Biochem Biophys Res Commun VL - 486 UR - https://doi.org/10.1016/j.bbrc.2017.02.128 DO - 10.1016/j.bbrc.2017.02.128 ID - Liu2017 ER - TY - JOUR AU - Luo, F. AU - Luo, M. AU - Rong, Q. X. AU - Zhang, H. AU - Chen, Z. AU - Wang, F. PY - 2019 DA - 2019// TI - Niclosamide, an antihelmintic drug, enhances efficacy of PD-1/PD-L1 immune checkpoint blockade in non-small cell lung cancer JO - J Immunother Cancer VL - 7 UR - https://doi.org/10.1186/s40425-019-0733-7 DO - 10.1186/s40425-019-0733-7 ID - Luo2019 ER - TY - STD TI - Bagley SJ, O'Rourke DM. Clinical investigation of CAR T cells for solid tumors: Lessons learned and future directions. Pharmacol Ther. 2019;107419. ID - ref170 ER - TY - JOUR AU - Du, H. AU - Hirabayashi, K. AU - Ahn, S. AU - Kren, N. P. AU - Montgomery, S. A. AU - Wang, X. PY - 2019 DA - 2019// TI - Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T Cells JO - Cancer Cell VL - 35 UR - https://doi.org/10.1016/j.ccell.2019.01.002 DO - 10.1016/j.ccell.2019.01.002 ID - Du2019 ER - TY - JOUR AU - Majzner, R. G. AU - Theruvath, J. L. AU - Nellan, A. AU - Heitzeneder, S. AU - Cui, Y. AU - Mount, C. W. PY - 2019 DA - 2019// TI - CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors JO - Clin Cancer Res VL - 25 UR - https://doi.org/10.1158/1078-0432.CCR-18-0432 DO - 10.1158/1078-0432.CCR-18-0432 ID - Majzner2019 ER - TY - JOUR AU - Fraietta, J. A. AU - Lacey, S. F. AU - Orlando, E. J. AU - Pruteanu-Malinici, I. AU - Gohil, M. AU - Lundh, S. PY - 2018 DA - 2018// TI - Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia JO - Nat Med VL - 24 UR - https://doi.org/10.1038/s41591-018-0010-1 DO - 10.1038/s41591-018-0010-1 ID - Fraietta2018 ER - TY - JOUR AU - Kagoya, Y. AU - Tanaka, S. AU - Guo, T. AU - Anczurowski, M. AU - Wang, C. H. AU - Saso, K. PY - 2018 DA - 2018// TI - A novel chimeric antigen receptor containing a JAK-STAT signaling domain mediates superior antitumor effects JO - Nat Med VL - 24 UR - https://doi.org/10.1038/nm.4478 DO - 10.1038/nm.4478 ID - Kagoya2018 ER - TY - JOUR AU - Wang, Y. AU - Jiang, H. AU - Luo, H. AU - Sun, Y. AU - Shi, B. AU - Sun, R. PY - 2019 DA - 2019// TI - An IL-4/21 Inverted Cytokine Receptor Improving CAR-T Cell Potency in Immunosuppressive Solid-Tumor Microenvironment JO - Front Immunol VL - 10 UR - https://doi.org/10.3389/fimmu.2019.01691 DO - 10.3389/fimmu.2019.01691 ID - Wang2019 ER - TY - JOUR AU - Shah, N. N. AU - Fry, T. J. PY - 2019 DA - 2019// TI - Mechanisms of resistance to CAR T cell therapy JO - Nat Rev Clin Oncol VL - 16 ID - Shah2019 ER - TY - JOUR AU - Guha, P. AU - Gardell, J. AU - Darpolor, J. AU - Cunetta, M. AU - Lima, M. AU - Miller, G. PY - 2019 DA - 2019// TI - STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells JO - Oncogene. VL - 38 UR - https://doi.org/10.1038/s41388-018-0449-z DO - 10.1038/s41388-018-0449-z ID - Guha2019 ER - TY - JOUR AU - Corrales, L. AU - McWhirter, S. M. AU - Dubensky, T. W. AU - Gajewski, T. F. PY - 2016 DA - 2016// TI - The host STING pathway at the interface of cancer and immunity JO - J Clin Invest VL - 126 UR - https://doi.org/10.1172/JCI86892 DO - 10.1172/JCI86892 ID - Corrales2016 ER - TY - JOUR AU - Ramanjulu, J. M. AU - Pesiridis, G. S. AU - Yang, J. AU - Concha, N. AU - Singhaus, R. AU - Zhang, S. Y. PY - 2018 DA - 2018// TI - Design of amidobenzimidazole STING receptor agonists with systemic activity JO - Nature. VL - 564 UR - https://doi.org/10.1038/s41586-018-0705-y DO - 10.1038/s41586-018-0705-y ID - Ramanjulu2018 ER - TY - JOUR AU - Shae, D. AU - Becker, K. W. AU - Christov, P. AU - Yun, D. S. AU - Lytton-Jean, A. K. R. AU - Sevimli, S. PY - 2019 DA - 2019// TI - Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy JO - Nat Nanotechnol VL - 14 UR - https://doi.org/10.1038/s41565-018-0342-5 DO - 10.1038/s41565-018-0342-5 ID - Shae2019 ER - TY - JOUR AU - Zhu, Q. AU - Man, S. M. AU - Gurung, P. AU - Liu, Z. AU - Vogel, P. AU - Lamkanfi, M. PY - 2014 DA - 2014// TI - Cutting edge: STING mediates protection against colorectal tumorigenesis by governing the magnitude of intestinal inflammation JO - J Immunol VL - 193 UR - https://doi.org/10.4049/jimmunol.1402051 DO - 10.4049/jimmunol.1402051 ID - Zhu2014 ER - TY - JOUR AU - Zhang, C. X. AU - Ye, S. B. AU - Ni, J. J. AU - Cai, T. T. AU - Liu, Y. N. AU - Huang, D. J. PY - 2019 DA - 2019// TI - STING signaling remodels the tumor microenvironment by antagonizing myeloid-derived suppressor cell expansion JO - Cell Death Differ VL - 26 UR - https://doi.org/10.1038/s41418-019-0302-0 DO - 10.1038/s41418-019-0302-0 ID - Zhang2019 ER - TY - JOUR AU - Hsia, H. C. AU - Hutti, J. E. AU - Baldwin, A. S. PY - 2017 DA - 2017// TI - Cytosolic DNA Promotes Signal Transducer and Activator of Transcription 3 (STAT3) Phosphorylation by TANK-binding Kinase 1 (TBK1) to Restrain STAT3 Activity JO - J Biol Chem VL - 292 UR - https://doi.org/10.1074/jbc.M116.771964 DO - 10.1074/jbc.M116.771964 ID - Hsia2017 ER - TY - JOUR AU - Moreira, D. AU - Adamus, T. AU - Zhao, X. AU - Su, Y. L. AU - Zhang, Z. AU - White, S. V. PY - 2018 DA - 2018// TI - STAT3 Inhibition Combined with CpG Immunostimulation Activates Antitumor Immunity to Eradicate Genetically Distinct Castration-Resistant Prostate Cancers JO - Clin Cancer Res VL - 24 UR - https://doi.org/10.1158/1078-0432.CCR-18-1277 DO - 10.1158/1078-0432.CCR-18-1277 ID - Moreira2018 ER - TY - JOUR AU - Nefedova, Y. AU - Nagaraj, S. AU - Rosenbauer, A. AU - Muro-Cacho, C. AU - Sebti, S. M. AU - Gabrilovich, D. I. PY - 2005 DA - 2005// TI - Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathway JO - Cancer Res VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-05-0529 DO - 10.1158/0008-5472.CAN-05-0529 ID - Nefedova2005 ER -